254 related articles for article (PubMed ID: 20739455)
21. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
22. Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance.
Morgan MM; Clayton CC; Lane DA
Neuroscience; 2003; 118(1):227-32. PubMed ID: 12676152
[TBL] [Abstract][Full Text] [Related]
23. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray.
Meyer PJ; Fossum EN; Ingram SL; Morgan MM
Neuropharmacology; 2007 Jun; 52(8):1580-5. PubMed ID: 17445843
[TBL] [Abstract][Full Text] [Related]
24. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats.
Ingram SL; Fossum EN; Morgan MM
Neuropsychopharmacology; 2007 Mar; 32(3):600-6. PubMed ID: 16823389
[TBL] [Abstract][Full Text] [Related]
25. Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons.
Zhu W; Pan ZZ
Neuroscience; 2005; 133(1):97-103. PubMed ID: 15893634
[TBL] [Abstract][Full Text] [Related]
26. Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.
Osborne PB; Chieng B; Christie MJ
Br J Pharmacol; 2000 Dec; 131(7):1422-8. PubMed ID: 11090116
[TBL] [Abstract][Full Text] [Related]
27. Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
Lamberts JT; Smith CE; Li MH; Ingram SL; Neubig RR; Traynor JR
J Neurosci; 2013 Mar; 33(10):4369-77. PubMed ID: 23467353
[TBL] [Abstract][Full Text] [Related]
28. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
Vaughan CW; Bagley EE; Drew GM; Schuller A; Pintar JE; Hack SP; Christie MJ
Br J Pharmacol; 2003 May; 139(2):362-7. PubMed ID: 12770941
[TBL] [Abstract][Full Text] [Related]
29. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
30. Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment.
Hack SP; Bagley EE; Chieng BC; Christie MJ
J Neurosci; 2005 Mar; 25(12):3192-8. PubMed ID: 15788776
[TBL] [Abstract][Full Text] [Related]
31. Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition.
Pan YZ; Li DP; Chen SR; Pan HL
Brain Res; 2004 Jan; 997(1):67-78. PubMed ID: 14715151
[TBL] [Abstract][Full Text] [Related]
32. Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.
Takasu K; Ogawa K; Nakamura A; Kanbara T; Ono H; Tomii T; Morioka Y; Hasegawa M; Shibasaki M; Mori T; Suzuki T; Sakaguchi G
Br J Pharmacol; 2015 Apr; 172(8):2148-64. PubMed ID: 25521524
[TBL] [Abstract][Full Text] [Related]
33. Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.
Bailey CP; Llorente J; Gabra BH; Smith FL; Dewey WL; Kelly E; Henderson G
Eur J Neurosci; 2009 Jan; 29(2):307-18. PubMed ID: 19200236
[TBL] [Abstract][Full Text] [Related]
34. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
35. Contribution of adenylyl cyclase modulation of pre- and postsynaptic GABA neurotransmission to morphine antinociception and tolerance.
Bobeck EN; Chen Q; Morgan MM; Ingram SL
Neuropsychopharmacology; 2014 Aug; 39(9):2142-52. PubMed ID: 24622471
[TBL] [Abstract][Full Text] [Related]
36. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
37. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
Hoffman AF; Lupica CR
J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
[TBL] [Abstract][Full Text] [Related]
38. Activation of mu-opioid receptors in the ventrolateral orbital cortex inhibits the GABAergic miniature inhibitory postsynaptic currents in rats.
Qu CL; Huo FQ; Huang FS; Tang JS
Neurosci Lett; 2015 Apr; 592():64-9. PubMed ID: 25711796
[TBL] [Abstract][Full Text] [Related]
39. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
40. Functionally selective signaling for morphine and fentanyl antinociception and tolerance mediated by the rat periaqueductal gray.
Morgan MM; Reid RA; Saville KA
PLoS One; 2014; 9(12):e114269. PubMed ID: 25503060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
